Business Wire

Aspen REIT’s Initial Public Offering is Qualified by SEC

Jaa

Aspen REIT, Inc. ( “Aspen REIT”), a recently-formed, single-asset real estate investment trust (“REIT”), today announced that its offering statement on Form 1-A filed with the Securities and Exchange Commission (“SEC”) in connection with its planned $33.5 million Regulation A+ initial public offering (the “IPO”) has been qualified by the SEC. Aspen REIT is offering 1,675,000 shares at $20.00 per share in the IPO. Aspen REIT has applied to list its common stock on the NYSE American stock exchange under the ticker symbol “AJAX.”

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180124005593/en/

St. Regis Aspen Resort in Aspen, Colorado (Photo: Business Wire)

St. Regis Aspen Resort in Aspen, Colorado (Photo: Business Wire)

Upon closing of the IPO, Aspen REIT will be the first single-asset REIT to list on a national securities exchange in the United States. Aspen REIT intends to use substantially all of the net proceeds from the IPO, together with equity in Aspen REIT’s subsidiary operating partnership, to acquire the renowned St. Regis Aspen Resort in Aspen, Colorado (the “St. Regis Aspen”).

Investors may subscribe for shares of common stock of Aspen REIT in the IPO or indicate an interest in subscribing for shares at www.m-vest.com/aspenreit.

Maxim Group LLC is the lead managing selling agent for the offering.

“Today, any investor can subscribe to become a part owner in the St. Regis Aspen Resort, one of the world’s finest luxury hotels,” said Stephane De Baets, Chief Executive Officer, President and Chairman of Aspen REIT. “Through this first-of-its-kind offering in the United States, we are leveling the playing field for all investors, creating equal opportunity to participate in the upside associated with a first-class resort destination supported by strong fundamentals, an experienced leadership team and a world-class property manager.”

Individuals interested in investing and learning more about Aspen REIT and the IPO can register an indication of interest or subscribe for shares by visiting www.m-vest.com/aspenreit, or by calling (800) 645-9144. For additional information on Aspen REIT, the IPO and any other related topics, please review the Form 1-A offering circular that can be found at: www.m-vest.com/aspenreit.

About Aspen REIT

Aspen REIT, Inc. is a recently-formed company that intends to own the St. Regis Aspen Resort, a full-service, 179-room luxury hotel with four onsite food and beverage outlets and 29,000 square feet of indoor and outdoor conference and banquet venues with views of the Rocky Mountains. The St. Regis Aspen is managed by a subsidiary of Marriott International Inc. The St. Regis Aspen is located in the famous resort town of Aspen, Colorado, home of year-round events such as The World Cup ski races, The ESPN Winter X Games, The Food & Wine Classic, and The Aspen Music Festival. Aspen REIT intends to be the first single-asset REIT to list on a national exchange and is externally managed by a majority-owned subsidiary of Elevated Returns LLC, a New York-based real estate asset management and advisory firm.

Cautionary Note Regarding Forward-Looking Statements

This press release may include “forward-looking statements.” To the extent that the information presented in this press release discusses financial projections, information, or expectations about the potential closing of the IPO, our business plans, results of operations, the St. Regis Aspen or the Aspen resort market, or otherwise makes statements about future events, such statements are forward-looking. Such forward-looking statements can be identified by the use of words such as “should,” “may,” “intends,” “anticipates,” “believes,” “estimates,” “projects,” “forecasts,” “expects,” “plans,” and “proposes.” Although we believe that the expectations reflected in these forward-looking statements are based on reasonable assumptions, there are a number of risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading "Risk Factors" and elsewhere in the offering statement that we will file with the SEC. Forward-looking statements speak only as of the date of the document in which they are contained, and Aspen REIT, Inc. does not undertake any duty to update any forward-looking statements except as may be required by law.

Legal Disclaimer

The offering will be made only by means of an offering circular. An offering statement on Form 1-A relating to these securities has been filed with the Securities and Exchange Commission and become qualified on January 23, 2018. The securities offered by Aspen REIT are highly speculative. Investing in shares of Aspen REIT involves significant risks. The investment is suitable only for persons who can afford to lose their entire investment. No public market currently exists for the securities, and if a public market develops following the offering, it may not continue. Aspen REIT intends to list its securities on a national exchange and doing so entails significant ongoing corporate obligations including but not limited to disclosure, filing and notification requirements, as well as compliance with applicable continued quantitative and qualitative listing standards. Prior to any investment in Aspen REIT’s common stock, you should review a copy of the Form 1-A offering circular by clicking on the following link, https://www.sec.gov/Archives/edgar/data/1694997/000110465918003656/a17-17001_5253g1.htm, or by contacting Maxim Group LLC, by phone at 1-800-645-9144 or by visiting www.m-vest.com/aspenreit.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Contact information

Lead Selling Agent:
Maxim Group LLC
Joseph Rallo, (800) 537-6923
jrallo@maximgrp.com
or
Vera Carbone, (800) 537-6923
vcarbone@maximgrp.com
or
Media:
ICR
Jason Chudoba, 646-277-1249
Jason.Chudoba@icrinc.com
or
Matthew Chudoba, 203-682-8217
Matthew.Chudoba@icrinc.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Patient-Data Platform Raremark Raises £3m to Enable Precision Medicine in Rare Disease22.10.2018 15:00Tiedote

Raremark, the leading patient-data platform in rare disease, has raised £3m in funding from investors, led by AlbionVC and Ananda Ventures, with participation from Oltre Venture and from existing major investor the Cass Entrepreneurship Fund. The funding will be used to develop Raremark’s patient-engagement and data-analysis technology, helping biopharmaceutical companies to identify, engage and learn from patients, accelerating the development of new treatments. Raremark’s platform is the foundation for building research networks of rare disease patients and their families. Raremark provides biopharmaceutical companies with access to anonymized and aggregated patient data, helping to reduce the time and cost of clinical development. The Raremark platform engages and retains patients, leveraging machine-learning technologies in novel ways. The approach is designed to raise health literacy and informed participation in medical research, to improve the quality of existing therapies and t

Celltrion Healthcare Hosts Forum with Patient Advocacy Groups to Provide Information on the Use of Biosimilars in Oncology22.10.2018 14:50Tiedote

To coincide with the ESMO 2018 Congress in Munich, Germany, Celltrion Healthcare invited perspective from experts including a physician and pharmacist to provide information to patient advocacy groups on the history of biosimilars, how they are tested and approved, their cost saving benefit and the wealth of clinical evidence already available on their use in order to improve understanding of biosimilars. The introduction of biosimilars in the treatment of cancer has the potential to reduce pressure on healthcare budgets and increase access to other innovative treatments or more potent regimens. This is achieved by offering more cost-effective alternatives to the reference medicinal products and by increasing competition in the market. Breast cancer is the most common cancer in women worldwide and accounts for a quarter of all cancer diagnoses in women.1 For the benefits of biosimilar use to be realised in oncology, and in the treatment of breast cancer, barriers to their uptake need t

Sony Corporation Selects ANAQUA for IP Management22.10.2018 14:00Tiedote

Anaqua, Inc., the leading provider of innovation and intellectual property (IP) management solutions, today announced that multinational technology company Sony Corporation has entered into a multi-year agreement to use the ANAQUA software to manage its patent and trademark portfolios. Sony is one of the world’s largest technology and entertainment companies, with products spanning consumer electronics, smart phones, game and network services, financial services, and professional products. “We are excited to welcome one of the world’s largest companies and IP leaders to Anaqua’s growing client community,” said Bob Romeo, CEO of Anaqua. “Sony’s decision to strategically partner with Anaqua for their IP Management system reinforces our continued investment in the APAC market.” ABOUT ANAQUA The most innovative companies in the world innovate with Anaqua. Its simplified software platform combines insight from big data analytics with critical tools, best practice workflows and advanced serv

Dentsu Aegis Network Announces the Acquisition of Namics AG22.10.2018 14:00Tiedote

Dentsu Aegis Network today announces that it has signed a definitive agreement to acquire Namics AG, a leading full-service digital agency in Switzerland and Germany. Following the acquisition, which is subject to approval from the German competition authority, the company will become ‘Namics - A Merkle Company’. Namics’ digital experience, creative and service design expertise complements Merkle’s already significant customer experience (CX) and marketing technology practice in the region. An important step in Merkle’s strategy to increase its global footprint, it provides further scale and depth to Merkle’s people-based marketing capabilities, in particular in the areas of business transformation strategy, digital consulting and technology implementation across Adobe Experience Cloud, Sitecore, Salesforce and SAP and other leading technology partners. All Namics‘ 550 digital specialists based in Frankfurt, Hamburg, Munich, St. Gallen, Zurich and Belgrade will join Merkle, bringing it

4th International Conference on the Economics of Happiness 2018 to Be Held in Jeonju22.10.2018 14:00Tiedote

The 4th International Conference on the Economics of Happiness 2018 Jeonju will be held on November 8~9, 2018 at the Korea Traditional Culture Center in Jeonju to explore solutions for happiness and better future of citizens. Jeonju is the most unique Korean city and a typical tourist destination in Asia that has successfully preserved Korean traditional culture. With participation by experts in human, ecosystemic and social economics as well as leaders in organizations and entrepreneurs, including Helena Norberg Hodge, President of Local Futures, the International Conference on the Economics of Happiness 2018 will feature lectures and discussions to share experiences and present a vision under the subtitle of the ‘Strategy for Localization’. Starting with a keynote address by President Hodge, Junko Edahiro, President of the Institute for Studies in Happiness, Economy and Society in Japan, Takahashi Hiromichi, CEO of PAL System, and Jay Tompt, Professor of Economics at University of Pl

E2open to Acquire INTTRA, Adding the World’s Leading Ocean Shipping Network and Software Provider, Creating an Integrated Global Supply Chain and Logistics Operating Network22.10.2018 13:00Tiedote

E2open, the one place in the cloud to run your supply chain, today announced the acquisition of INTTRA, the leading ocean shipping network, software and information provider. The combination of INTTRA’s ocean carrier and shipper network with E2open’s industry leading business network will create a unified global logistics and supply chain network. E2open and INTTRA will join efforts to strengthen the connections and streamline the information flow between manufacturers, suppliers, shipping service providers, ocean carriers and all the participants in global trade. E2open is the largest cloud-based provider of networked supply chain solutions, featuring a complete portfolio of applications that enable the world’s most complex supply chains to better plan, collaborate, and execute their end-to-end operations. More than 70,000 partner companies and 200,000 users, many of the biggest brands and manufacturers across a range of industries, use the E2open network and platform to orchestrate t

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme